{"DataElement":{"publicId":"13567111","version":"1","preferredName":"Primary Tumor Laterality Type","preferredDefinition":"The text term to designate the side of the body on which the tumor is located.","longName":"2188720v1.00:13567109v1.00","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"2188720","version":"1","preferredName":"Primary Tumor Laterality","preferredDefinition":"information related to primary tumor laterality.","longName":"PRM_TUMOR_LATERALITY","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206557","version":"1","preferredName":"Primary Neoplasm","preferredDefinition":"Occurring first in time or sequence; original. (American Heritage Dictionary):(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C25251:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F9B5-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177477","version":"1","preferredName":"Laterality","preferredDefinition":"Laterality; having to do with the use or development of one side of the body versus the other.","longName":"Laterality","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Laterality","conceptCode":"C25185","definition":"Dominant use or manifestations of one side of the body versus the other; referring to a side of the body or of a structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-5226-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E54DA74F-8045-61CF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"13567109","version":"1","preferredName":"Tumor Laterality Type","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Dominant use or manifestations of one side of the body versus the other; referring to a side of the body or of a structure._Something distinguishable as an identifiable class based on common qualities.","longName":"13567109v1.00","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Right (cecum to distal 2/3 transverse colon)","valueDescription":null,"ValueMeaning":{"publicId":"13567110","version":"1","preferredName":"Right (cecum to distal 2/3 transverse colon)","longName":"13567110v1.00","preferredDefinition":"Right (cecum to distal 2/3 transverse colon)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB6EFF1D-6B13-642F-E053-731AD00ADE8F","latestVersionIndicator":"Yes","beginDate":"2023-05-11","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-11","modifiedBy":"FINCHAMB","dateModified":"2023-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB6EFF1D-6B14-642F-E053-731AD00ADE8F","beginDate":"2023-05-11","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-11","modifiedBy":"FINCHAMB","dateModified":"2023-05-11","deletedIndicator":"No"},{"value":"Left (distal 1/3 transverse colon to sigmoid)/rectum","valueDescription":null,"ValueMeaning":{"publicId":"13567112","version":"1","preferredName":"Left (distal 1/3 transverse colon to sigmoid)/rectum","longName":"13567112v1.00","preferredDefinition":"Left (distal 1/3 transverse colon to sigmoid)/rectum","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB6F31C7-E1F5-6DBC-E053-731AD00A56CE","latestVersionIndicator":"Yes","beginDate":"2023-05-11","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-11","modifiedBy":"FINCHAMB","dateModified":"2023-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB6F31C7-E1F6-6DBC-E053-731AD00A56CE","beginDate":"2023-05-11","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-11","modifiedBy":"FINCHAMB","dateModified":"2023-05-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"13567108","version":"1","preferredName":"Neoplasm Laterality Type","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Dominant use or manifestations of one side of the body versus the other; referring to a side of the body or of a structure._Something distinguishable as an identifiable class based on common qualities.","longName":"13567108v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Laterality","conceptCode":"C25185","definition":"Dominant use or manifestations of one side of the body versus the other; referring to a side of the body or of a structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB6EF61C-D85B-633A-E053-731AD00A5985","latestVersionIndicator":"Yes","beginDate":"2023-05-11","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-11","modifiedBy":"FINCHAMB","dateModified":"2023-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB6EF61C-D85C-633A-E053-731AD00A5985","latestVersionIndicator":"Yes","beginDate":"2023-05-11","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-11","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeDescription":null,"administrativeNotes":"5/11/23 Created for ECOG-ACRIN Stratification Factor Questions. BF","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Primary tumor sidedness","url":null,"context":"ECOG-ACRIN"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB6F252E-716E-6BC7-E053-731AD00A8801","latestVersionIndicator":"Yes","beginDate":"2023-05-11","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-11","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeDescription":null,"administrativeNotes":"5/11/23 Created for ECOG-ACRIN Stratification Factor Questions. BF","unresolvedIssues":null,"deletedIndicator":"No"}}